Log in

Collegium Pharmaceutical News Headlines (NASDAQ:COLL)

$11.56
-0.52 (-4.30 %)
(As of 10/21/2019 03:42 AM ET)
Today's Range
$11.47
Now: $11.56
$12.29
50-Day Range
$10.52
MA: $11.54
$12.81
52-Week Range
$10.01
Now: $11.56
$19.83
Volume263,851 shs
Average Volume315,521 shs
Market Capitalization$386.91 million
P/E RatioN/A
Dividend YieldN/A
Beta0.52

Headlines

Collegium Pharmaceutical (NASDAQ COLL) News Headlines

Source:
DateHeadline
Collegium Pharmaceutical (NASDAQ:COLL) Given a $33.00 Price Target at Needham & Company LLCCollegium Pharmaceutical (NASDAQ:COLL) Given a $33.00 Price Target at Needham & Company LLC
www.americanbankingnews.com - October 20 at 10:12 PM
Collegium Pharmaceutical (NASDAQ:COLL) Has Debt But No Earnings; Should You Worry?Collegium Pharmaceutical (NASDAQ:COLL) Has Debt But No Earnings; Should You Worry?
finance.yahoo.com - October 19 at 12:04 PM
Zacks: Brokerages Anticipate Collegium Pharmaceutical Inc (NASDAQ:COLL) to Post -$0.16 EPSZacks: Brokerages Anticipate Collegium Pharmaceutical Inc (NASDAQ:COLL) to Post -$0.16 EPS
www.americanbankingnews.com - October 19 at 7:25 AM
Q3 2019 EPS Estimates for Collegium Pharmaceutical Inc Cut by Analyst (NASDAQ:COLL)Q3 2019 EPS Estimates for Collegium Pharmaceutical Inc Cut by Analyst (NASDAQ:COLL)
www.americanbankingnews.com - October 18 at 6:46 AM
Collegium Pharmaceutical (NASDAQ:COLL) PT Set at $33.00 by Needham & Company LLCCollegium Pharmaceutical (NASDAQ:COLL) PT Set at $33.00 by Needham & Company LLC
www.americanbankingnews.com - October 14 at 3:42 PM
Calming and Sleeping Market Is Thriving Worldwide | - Cara Therapeutics Collegium Pharmaceutical & DurectCalming and Sleeping Market Is Thriving Worldwide | - Cara Therapeutics Collegium Pharmaceutical & Durect
www.marketwatch.com - October 11 at 10:30 AM
FY2019 EPS Estimates for Collegium Pharmaceutical Inc (NASDAQ:COLL) Decreased by AnalystFY2019 EPS Estimates for Collegium Pharmaceutical Inc (NASDAQ:COLL) Decreased by Analyst
www.americanbankingnews.com - October 10 at 7:57 AM
Collegium Pharmaceutical Inc (NASDAQ:COLL) Given Average Recommendation of "Buy" by AnalystsCollegium Pharmaceutical Inc (NASDAQ:COLL) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - October 10 at 5:28 AM
Collegium Pharmaceutical Inc (NASDAQ:COLL) Short Interest Down 7.0% in SeptemberCollegium Pharmaceutical Inc (NASDAQ:COLL) Short Interest Down 7.0% in September
www.americanbankingnews.com - September 29 at 1:37 PM
$75.98 Million in Sales Expected for Collegium Pharmaceutical Inc (NASDAQ:COLL) This Quarter$75.98 Million in Sales Expected for Collegium Pharmaceutical Inc (NASDAQ:COLL) This Quarter
www.americanbankingnews.com - September 28 at 3:08 AM
Zacks: Brokerages Expect Collegium Pharmaceutical Inc (NASDAQ:COLL) to Post -$0.11 Earnings Per ShareZacks: Brokerages Expect Collegium Pharmaceutical Inc (NASDAQ:COLL) to Post -$0.11 Earnings Per Share
www.americanbankingnews.com - September 26 at 7:05 PM
Collegium to Participate in Upcoming Investor ConferenceCollegium to Participate in Upcoming Investor Conference
finance.yahoo.com - September 25 at 5:32 PM
Collegium Announces Scientific Presentations at PAINWeek 2019 National ConferenceCollegium Announces Scientific Presentations at PAINWeek 2019 National Conference
finance.yahoo.com - August 29 at 11:58 PM
Collegium Pharmaceutical, Inc. (COLL) Q2 2019 Earnings Call TranscriptCollegium Pharmaceutical, Inc. (COLL) Q2 2019 Earnings Call Transcript
finance.yahoo.com - August 8 at 8:10 AM
Edited Transcript of COLL earnings conference call or presentation 7-Aug-19 8:30pm GMTEdited Transcript of COLL earnings conference call or presentation 7-Aug-19 8:30pm GMT
finance.yahoo.com - August 8 at 8:10 AM
Assertio Therapeutics, Inc. (ASRT) CEO Arthur Higgins on Q2 2019 Results - Earnings Call TranscriptAssertio Therapeutics, Inc. (ASRT) CEO Arthur Higgins on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 12:10 AM
Collegium Reports Second Quarter 2019 Financial ResultsCollegium Reports Second Quarter 2019 Financial Results
www.nasdaq.com - August 8 at 12:10 AM
Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q2 2019 Results - Earnings Call TranscriptCollegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 8 at 12:10 AM
Collegium Pharmaceutical: 2Q Earnings SnapshotCollegium Pharmaceutical: 2Q Earnings Snapshot
finance.yahoo.com - August 8 at 12:10 AM
Collegium Pharmaceutical (COLL) Q2 Earnings Surpass EstimatesCollegium Pharmaceutical (COLL) Q2 Earnings Surpass Estimates
finance.yahoo.com - August 8 at 12:10 AM
Collegium Pharmaceutical Q2 2019 Earnings PreviewCollegium Pharmaceutical Q2 2019 Earnings Preview
seekingalpha.com - August 7 at 12:35 AM
Earnings Preview: Collegium Pharmaceutical (COLL) Q2 Earnings Expected to DeclineEarnings Preview: Collegium Pharmaceutical (COLL) Q2 Earnings Expected to Decline
finance.yahoo.com - July 31 at 6:01 PM
Collegium to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Provide Corporate UpdateCollegium to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Provide Corporate Update
finance.yahoo.com - July 25 at 12:16 AM
Imagine Owning Collegium Pharmaceutical (NASDAQ:COLL) And Wondering If The 48% Share Price Slide Is JustifiedImagine Owning Collegium Pharmaceutical (NASDAQ:COLL) And Wondering If The 48% Share Price Slide Is Justified
finance.yahoo.com - July 24 at 5:14 AM
Assertio Therapeutics Turnaround Is At A Complete Stop, Value Investors BewareAssertio Therapeutics' Turnaround Is At A Complete Stop, Value Investors Beware
seekingalpha.com - July 10 at 7:16 PM
Collegium Pharmaceutical, Inc.: Getting A Second Chance To BuyCollegium Pharmaceutical, Inc.: Getting A Second Chance To Buy
seekingalpha.com - June 24 at 5:15 PM
Hedge Funds Have Never Been This Bullish On Collegium Pharmaceutical Inc (COLL)Hedge Funds Have Never Been This Bullish On Collegium Pharmaceutical Inc (COLL)
finance.yahoo.com - June 20 at 5:11 AM
Allergy Treatment Market to Witness Massive Growth by 2025: GlaxoSmithKline, Allergy therapeutics,Allergopharma (Merck), Allergon HealthcareAllergy Treatment Market to Witness Massive Growth by 2025: GlaxoSmithKline, Allergy therapeutics,Allergopharma (Merck), Allergon Healthcare
www.marketwatch.com - May 16 at 9:39 AM
Collegium Pharmaceutical, Inc. (COLL) Q1 2019 Earnings Call TranscriptCollegium Pharmaceutical, Inc. (COLL) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 10 at 10:02 AM
Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q1 2019 Results - Earnings Call TranscriptCollegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 10:02 AM
Collegium Pharmaceutical (COLL) Reports Q1 Loss, Tops Revenue EstimatesCollegium Pharmaceutical (COLL) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 9 at 10:02 AM
Edited Transcript of COLL earnings conference call or presentation 8-May-19 8:30pm GMTEdited Transcript of COLL earnings conference call or presentation 8-May-19 8:30pm GMT
finance.yahoo.com - May 9 at 10:02 AM
Collegium Reports First Quarter 2019 Financial ResultsCollegium Reports First Quarter 2019 Financial Results
www.globenewswire.com - May 8 at 5:48 PM
Collegium Pharmaceutical Q1 Earnings PreviewCollegium Pharmaceutical Q1 Earnings Preview
seekingalpha.com - May 8 at 9:53 AM
Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy?Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy?
finance.yahoo.com - May 1 at 5:40 PM
Collegium to Participate in Upcoming Investor ConferencesCollegium to Participate in Upcoming Investor Conferences
finance.yahoo.com - April 30 at 5:32 PM
Collegium to Host Conference Call to Discuss First Quarter 2019 Financial Results and Provide Corporate UpdateCollegium to Host Conference Call to Discuss First Quarter 2019 Financial Results and Provide Corporate Update
finance.yahoo.com - April 24 at 5:32 PM
Collegium Appoints Richard Malamut, M.D., as Chief Medical OfficerCollegium Appoints Richard Malamut, M.D., as Chief Medical Officer
finance.yahoo.com - April 2 at 1:10 PM
Read This Before Buying Collegium Pharmaceutical, Inc. (NASDAQ:COLL) SharesRead This Before Buying Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares
finance.yahoo.com - March 31 at 5:15 PM
Collegium Pharmaceutical (COLL) Upgraded to Buy: What Does It Mean for the Stock?Collegium Pharmaceutical (COLL) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - March 25 at 10:25 AM
Assertio Therapeutics, Inc (ASRT) Q4 2018 Earnings Conference Call TranscriptAssertio Therapeutics, Inc (ASRT) Q4 2018 Earnings Conference Call Transcript
finance.yahoo.com - March 14 at 10:38 AM
Collegium Pharmaceuticals: Post-Q4 AssessmentCollegium Pharmaceuticals: Post-Q4 Assessment
seekingalpha.com - March 13 at 5:31 PM
Assertio Therapeutics Announces Fourth-Quarter and Full-Year 2018 Financial ResultsAssertio Therapeutics Announces Fourth-Quarter and Full-Year 2018 Financial Results
globenewswire.com - March 6 at 5:52 PM
Collegium Pharmaceutical: Some Comforting DevelopmentsCollegium Pharmaceutical: Some Comforting Developments
seekingalpha.com - March 4 at 8:02 AM
Edited Transcript of COLL earnings conference call or presentation 27-Feb-19 9:30pm GMTEdited Transcript of COLL earnings conference call or presentation 27-Feb-19 9:30pm GMT
finance.yahoo.com - February 28 at 5:19 PM
Collegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q4 2018 Results - Earnings Call TranscriptCollegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - February 28 at 10:03 AM
Collegium Pharmaceutical Inc (COLL) Q4 2018 Earnings Conference Call TranscriptCollegium Pharmaceutical Inc (COLL) Q4 2018 Earnings Conference Call Transcript
www.fool.com - February 27 at 8:35 PM
Collegium Reports Fourth-Quarter and Full-Year 2018 Financial ResultsCollegium Reports Fourth-Quarter and Full-Year 2018 Financial Results
finance.yahoo.com - February 27 at 5:35 PM
Collegium Pharmaceutical Q4 Earnings PreviewCollegium Pharmaceutical Q4 Earnings Preview
seekingalpha.com - February 27 at 10:03 AM
Collegium Pharmaceutical (COLL) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseCollegium Pharmaceutical (COLL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - February 20 at 5:39 PM
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Featured Article: Monthly Dividend Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel